LTGO
Latigo Biotherapeutics, Inc.
23 disclosed insider filings · 3 distinct insiders · latest Aug 10, 2026
Total filings
23
3 insiders
Insider buys
2
$5.0M
Insider sells
0
$0
Grants & other
0
$0
All disclosed filings
Same-day tranches are grouped per insider - the Lots column shows how many individual executions a row covers; Price is the value-weighted average.
| Filed | Tx date | Insider | Type | Qty | Avg price | Value | Lots | Source |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Aug 10, 2026 | Beth C Seidenberg INSIDER | OTHER | 12,695,305 | — | — | 7 | EDGAR |
| Aug 10, 2026 | Aug 10, 2026 | James B Tananbaum INSIDER | BUY | 140,000 | $18 | $2.5M | — | EDGAR |
| Aug 10, 2026 | Aug 10, 2026 | James B Tananbaum INSIDER | OTHER | 9,041,328 | — | — | 7 | EDGAR |
| Aug 10, 2026 | Aug 10, 2026 | Foresite Capital Management V LLC 10% OWNER | OTHER | 9,041,328 | — | — | 7 | EDGAR |
| Aug 10, 2026 | Aug 10, 2026 | Foresite Capital Management V LLC 10% OWNER | BUY | 140,000 | $18 | $2.5M | — | EDGAR |